Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | MMP1 | P03956 | 1/20 | 0.42 |
| ▸ | MMP2 | P08253 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10384368 | 0.83 | MEN1 (0.48) | ALDH1A1LMNAHPGDGAAMEN1 | |
| SCHEMBL10649915 | 0.83 | ALOX15 (0.46) | ALDH1A1LMNAKMT2AMAPTCYP1A2 | |
| SCHEMBL10858706 | 0.82 | ALOX5 (0.55) | CYP2C19CYP2D6LMNAHPGDMAPT | |
| SCHEMBL10860569 | 0.82 | KMT2A (0.48) | CYP2C19HPGDKMT2AMAPTCYP1A2 | |
| SCHEMBL10859104 | 0.82 | CYP19A1 (0.39) | ALDH1A1CYP2C19CYP2D6LMNAALOX12 | |
| SCHEMBL10383500 | 0.82 | ATG4B (0.47) | ALDH1A1LMNAHPGDPOLBCASP3 | |
| SCHEMBL10383507 | 0.82 | MMP13 (0.47) | ALDH1A1CYP2C19CYP2D6HPGDCYP2C9 | |
| SCHEMBL7769614 | 0.82 | HTT (0.54) | ALDH1A1LMNAPOLBMAPT | |
| SCHEMBL6677679 | 0.81 | CYP19A1 (0.44) | ALDH1A1ALOX12HPGDGAAMEN1 | |
| SCHEMBL1273847 | 0.79 | ALDH1A1 (0.60) | ALDH1A1CYP2C19CYP2D6LMNAALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102656230-B | Guanidine derivative is as the purposes of epoxy resin curing accelerator | Aozer Chemical Co.,Ltd. (DE) | 2016-04-06 | — | — | CN | claimed |
| US-9238706-B2 | Use of guanidine derivatives as curing accelerators for epoxy resins | ALZCHEM AG (DE) | 2016-01-19 | — | — | US | claimed |
| EP-2496642-B1 | USE OF GUANIDINE DERIVATIVES AS CURING ACCELERATORS FOR EPOXY RESINS | ALZCHEM AG (DE) | 2014-10-29 | — | — | EP | claimed |
| EP-2496642-A2 | USE OF GUANIDINE DERIVATIVES AS CURING ACCELERATORS FOR EPOXY RESINS | AlzChem AG (DE) | 2012-09-12 | — | — | EP | claimed |
| CN-102656230-A | Use of guanidine derivatives as curing accelerators for epoxy resins | ALZCHEM TROSTBERG GMBH | 2012-09-05 | — | — | CN | claimed |
| US-20120208925-A1 | USE OF GUANIDINE DERIVATIVES AS CURING ACCELERATORS FOR EPOXY RESINS | ALZCHEM TROSTBERG GMBH (DE) | 2012-08-16 | — | — | US | claimed |
| WO-2011054945-A2 | USE OF GUANIDINE DERIVATIVES AS CURING ACCELERATORS FOR EPOXY RESINS | ALZCHEM TROSTBERG GMBH (DE) | 2011-05-12 | — | — | WO | claimed |
| US-6680408-B2 | REACTING S-METHYL NITROISOTHIOUREA WITH ALPHA-ETHYLBENZYLAMINE IN THE PRESENCE OF WATER AND ETHANOL MIXTURES TO FORM 1-(ALPHA-ETHYLBENZYL)-3-NITROGUANIDINE, USED AS PREEMERGENCE HERBICIDES | BAYER CROPSCIENCE LP | 2004-01-20 | — | — | US | claimed |
| US-20030236168-A1 | PROCESSES FOR THE PREPARATION OF ALPHA-SUBSTITUTED BENZYLNITROGUANIDINES | BAYER CORPORATION | 2003-12-25 | — | — | US | claimed |
| US-4944788-A | Substituted nitro and cyanoguanidines and their use for increasing crop yields | AMERICAN CYANAMID COMPANY (US) | 1990-07-31 | — | — | US | claimed |
| EP-0113070-B1 | THE USE OF SUBSTITUTED NITRO AND CYANOGUANIDINES FOR INCREASING CROP YIELD | AMERICAN CYANAMID COMPANY (US) | 1988-01-13 | — | — | EP | claimed |
| EP-0113070-A1 | The use of substituted nitro and cyanoguanidines for increasing crop yield | AMERICAN CYANAMID COMPANY (US) | 1984-07-11 | — | — | EP | claimed |
| US-20250257194-A1 | A METHOD FOR THE PREPARATION OF AN EPOXY RESIN COMPOSITION FOR THE PRE-IMPREGNATION OF MATERIALS | ALZCHEM TROSTBERG GMBH (DE) | 2025-08-14 | — | — | US | disclosed |
| EP-4562073-A1 | PROCESS FOR PRODUCING AN EPOXY RESIN COMPOSITION FOR PREIMPREGNATING MATERIALS | AlzChem Trostberg GmbH (DE) | 2025-06-04 | — | — | EP | disclosed |
| CN-119585337-A | Method for preparing epoxy resin composition for material pre-impregnation | 澳泽化学特罗斯特贝格有限公司 | 2025-03-07 | — | — | CN | disclosed |
| WO-2024022901-A1 | PROCESS FOR PRODUCING AN EPOXY RESIN COMPOSITION FOR PREIMPREGNATING MATERIALS | ALZCHEM TROSTBERG GMBH (DE) | 2024-02-01 | — | — | WO | disclosed |
| US-4639268-A | Nitro- and cyanoguanidines as selective preemergence herbicides and plant defoliants | AMERICAN CYANAMID COMPANY (US) | 1987-01-27 | — | — | US | disclosed |
| EP-0189579-A1 | Substituted nitro and cyanoguanidines and their use for increasing crop yield | AMERICAN CYANAMID COMPANY (US) | 1986-08-06 | — | — | EP | disclosed |
| US-4594092-A | Cytokinin-like response | AMERICAN CYANAMID COMPANY (US) | 1986-06-10 | — | — | US | disclosed |
| EP-0113070-A1 | The use of substituted nitro and cyanoguanidines for increasing crop yield | AMERICAN CYANAMID COMPANY (US) | 1984-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030236168-A1 | PROCESSES FOR THE PREPARATION OF ALPHA-SUBSTITUTED BENZYLNITROGUANIDINES | SRM, BPGM, GMPS | ALDH1A1 952/4885CYP2C19 546/4885CYP2D6 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.